Lytic bone metastases are rare in prostate cancer.
We here present 18 fluorine fluorodeoxyglucose (18F-FDG) positron emission tomography computed tomography (PET-CT) images of a 67-year-old male patient with lytic metastases from prostate cancer. Repeat 18F-FDG PET-CT done 6 months later showed response to medical castration therapy. While the role of 18F-FDG PET-CT for sclerotic bone metastases in prostate cancer remains controversial, it appears to be useful for detection and response assessment of lytic prostate cancer metastases.
Written by:
Sharma P, Karunanithi S, Singh Dhull V, Jain S, Bal C, Kumar R. Are you the author?
Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Reference: Indian J Nucl Med. 2013 Jul;28(3):178-9.
doi: 10.4103/0972-3919.119545
PubMed Abstract
PMID: 24250030
UroToday.com Bone Metastases Section
